Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.56
-0.06 (-0.24%)
At close: Apr 16, 2026, 4:00 PM EDT
25.04
+0.48 (1.95%)
After-hours: Apr 16, 2026, 7:45 PM EDT
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $744.07 million as of April 16, 2026. Its market cap has increased by 30.34% in one year.
Market Cap
744.07M
Enterprise Value
481.58M
1-Year Change
30.34%
Ranking
Category
Stock Price
$24.56
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $744.07M, an increase of 504.68%. That is a compound annual growth rate of 30.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 745.89M | -34.31% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.76B |
| GRAIL | 2.12B |
| GeneDx Holdings | 2.05B |
| NeoGenomics | 1.11B |
| CareDx | 925.48M |
| OPKO Health | 891.90M |
| Personalis | 709.72M |
| Myriad Genetics | 475.02M |